Pan-Canadian Initiative On Respiratory Disease
Links shared publicly online about this topic.
- 1,229total visits
Pan-Canadian Initiative On Respiratory Disease
View full resource at medicalnewstoday.com
Tags: COPD, Disease and Condition, Healthcare, disease
Most Recently Shared on April 19, 2010 at 2:12 pm By:
Pan-Canadian Initiative On Respiratory Disease http://mnt.to/3BqG #copd
Infectious Disease Article | Bordetella pertussis
mdlinx.com — “The respiratory pathology in infants with sudden unexpected deaths in whom respiratory specimens were initially PCR-positive or PCR-negative for Bordetella pertussis” View full resource at mdlinx.com
Most Recently Shared on July 27, 2011 at 12:42 pm By:
The respiratory pathology in infants with sudden unexpected deaths in whom respiratory specimens were initia... http://bit.ly/pkQoHT #ID
BD, Diagenode Collaborate to Expand Infectious Disease Menu on BD System | IVD Technology
ivdtechnology.com — “BD Diagnostics and Diagenode SA announced an agreement to co-develop seven initial molecular diagnostic assays on the BD MAX System for pathogens associated with respiratory, enteric and central nervous system diseases. --Our agreement with Diagenode represents the first milestone in BD--™s strategy to make BD MAX System an indispensible clinical laboratory tool that empowers laboratory professionals to provide rapid, accurate test results to clinicians needing the best inf” View full resource at ivdtechnology.com
Most Recently Shared on May 11, 2011 at 10:27 pm By:
BD, Diagenode Collaborate to Expand Infectious Disease Menu on BD System http://tinyurl.com/4xdln4p
Antibiotics cure anthrax in animal models
sciencedaily.com — “In the absence of early antibiotic treatment, respiratory anthrax is fatal. The 2001 bioterrorism attacks in the US killed four people, out of 22 infected (10 of them with respiratory anthrax), despite massive antibiotic administration, probably because therapy did not begin until the disease had reached the fulminant stage. But a multi-agent prophylaxis initiated within 24 hours post-infection prevented development of fatal anthrax respiratory disease, and treatment combining antibiotics with i” View full resource at sciencedaily.com
Most Recently Shared on April 20, 2011 at 6:30 pm By:
Antibiotics cure anthrax in animal models: In the absence of early antibiotic treatment, respiratory anthrax is ... http://bit.ly/hEu0uU
Antibiotics cure anthrax in animal models
sciencedaily.com — “In the absence of early antibiotic treatment, respiratory anthrax is fatal. The 2001 bioterrorism attacks in the US killed four people, out of 22 infected (10 of them with respiratory anthrax), despite massive antibiotic administration, probably because therapy did not begin until the disease had reached the fulminant stage. But a multi-agent prophylaxis initiated within 24 hours post-infection prevented development of fatal anthrax respiratory disease, and treatment combining antibiotics with i” View full resource at sciencedaily.com
Most Recently Shared on April 20, 2011 at 10:55 am By:
Antibiotics cure #anthrax in animal models http://t.co/hYfpkod via @AddThis #ID #QI #nurse #treatment
Antibiotics cure anthrax in animal models
sciencedaily.com — “In the absence of early antibiotic treatment, respiratory anthrax is fatal. The 2001 bioterrorism attacks in the US killed four people, out of 22 infected (10 of them with respiratory anthrax), despite massive antibiotic administration, probably because therapy did not begin until the disease had reached the fulminant stage. But a multi-agent prophylaxis initiated within 24 hours post-infection prevented development of fatal anthrax respiratory disease, and treatment combining antibiotics with i” View full resource at sciencedaily.com
Most Recently Shared on April 20, 2011 at 2:18 am By:
Antibiotics cure anthrax in animal models: In the absence of early antibiotic treatment, respiratory anthr... http://tinyurl.com/3rb3n96
Committee For Medicinal Products For Veterinary Use (CVMP) Meeting Of 8-10 March 2011 - QualityPoint Technologies
qualitypointtech.net — “The Committee adopted by consensus a positive opinion for an initial marketing authorisation application for Zuprevo (tildipirosin), from Intervet International BV, for the treatment of swine and bovine respiratory disease. The Committee adopted by consensus a positive opinion for an initial marketing authorisation application for CERTIFECT (fipronil, (s)-methoprene, amitraz), from MERIAL SAS, for the treatment and prevention of infestations in dogs by ticks, fleas and lice...” View full resource at qualitypointtech.net
Most Recently Shared on March 12, 2011 at 6:00 am By:
Committee For Medicinal Products For Veterinary Use (CVMP) Meeting Of 8-10 March 2011: The Committee adopted by co... http://bit.ly/fni2y8
Respiratory & Allergic Disease (RAD) Foundation - Learning Center
rad-foundation.org — “Respiratory & Allergic Disease Foundation. RAD is a not-for-profit organization founded by physicians. RAD recognizes the need for consistent, balanced, and high-quality education for healthcare practitioners focused on improving the quality of patient care. RAD is pleased to present a wide range of educational initiatives, including those developed with the guidance of our one-of-a-kind national educational faculty network, the Advancing Respiratory Care (ARC) Network.” View full resource at rad-foundation.org
Most Recently Shared on February 16, 2011 at 3:16 pm By:
Pediatrics Medical News about Asthma
mdlinx.com — “The Tennessee Children's Respiratory Initiative: Objectives, design and recruitment results of a prospective cohort study investigating infant viral respiratory illness and the development of asthma and allergic diseases” View full resource at mdlinx.com
Most Recently Shared on April 16, 2010 at 10:04 pm By:
The Tennessee Children's Respiratory Initiative: Objectives, design and recruitment results of a prospective ... http://bit.ly/9rre7H #peds
Aradigm initiates dosing in Phase 2b trial of inhaled liposomal ciprofloxacin formulations in BE patients
news-medical.net — “Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no” View full resource at news-medical.net
Most Recently Shared on February 23, 2010 at 1:32 pm By:
Aradigm initiates dosing in Phase 2b trial of inhaled liposomal ciprofloxacin formulations in BE patients: Aradigm... http://bit.ly/abhAXg
Respiratory & Allergic Disease (RAD) Foundation
rad-foundation.org — “Respiratory & Allergic Disease Foundation. RAD is a not-for-profit organization founded by physicians. RAD recognizes the need for consistent, balanced, and high-quality education for healthcare practitioners focused on improving the quality of patient care. RAD is pleased to present a wide range of educational initiatives, including those developed with the guidance of our one-of-a-kind national educational faculty network, the Advancing Respiratory Care (ARC) Network.” View full resource at rad-foundation.org
Most Recently Shared on September 17, 2009 at 7:25 pm By:
Practical Strategies for Managing IgE-Mediated Asthma: A Pulmonologist Opinion http://bit.ly/1YJMc
Respiratory & Allergic Disease (RAD) Foundation - Learning Center
rad-foundation.org — “Respiratory & Allergic Disease Foundation. RAD is a not-for-profit organization founded by physicians. RAD recognizes the need for consistent, balanced, and high-quality education for healthcare practitioners focused on improving the quality of patient care. RAD is pleased to present a wide range of educational initiatives, including those developed with the guidance of our one-of-a-kind national educational faculty network, the Advancing Respiratory Care (ARC) Network.” View full resource at rad-foundation.org
Most Recently Shared on September 17, 2009 at 7:24 pm By:
How Do the Pieces Fit? Atopy, Asthma, and Clinical Practice http://www.rad-foundation.org/intro.asp
Respiratory & Allergic Disease (RAD) Foundation
rad-foundation.org — “Respiratory & Allergic Disease Foundation. RAD is a not-for-profit organization founded by physicians. RAD recognizes the need for consistent, balanced, and high-quality education for healthcare practitioners focused on improving the quality of patient care. RAD is pleased to present a wide range of educational initiatives, including those developed with the guidance of our one-of-a-kind national educational faculty network, the Advancing Respiratory Care (ARC) Network.” View full resource at rad-foundation.org
Most Recently Shared on August 6, 2009 at 9:13 pm By:
“An Asthma Exchange with the Experts†podcast available at http://bit.ly/3XULmV
Advertisement

